Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Preliminary results
Quarterly results
Director departure
Appointed director
CC transcript
Alexza Pharmaceuticals Inc. (ALXA) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/01/2016 8-K Quarterly results
06/24/2016 8-K Form 8-K - Current report
06/21/2016 8-K Form 8-K - Current report
06/16/2016 8-K Form 8-K - Current report
05/11/2016 8-K Form 8-K - Current report
05/10/2016 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statement...
Docs: "Agreement and Plan of Merger by and among the Registrant, Grupo Ferrer Internacional, S.A. and Ferrer Pharma Inc. dated as of May 9, 2016. (Certain schedules referenced in the Merger Agreement have been omitted in accordance with Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule will be furnished supplementally to the U.S. Securities and Exchange Commission upon request.)",
"Amended and Restated Promissory Note issued by the Registrant to Grupo Ferrer Internacional, S.A.",
"Alexza Pharmaceuticals to be Acquired by Ferrer"
03/28/2016 8-K Form 8-K - Current report
03/09/2016 8-K Form 8-K - Current report
02/29/2016 8-K Form 8-K - Current report
02/24/2016 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Alexza Pharmaceuticals Reacquires U.S. Commercial Rights for ADASUVE ® inhalation powder"
01/22/2016 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
12/22/2015 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
Docs: "Alexza Pharmaceuticals Announces Receipt of NASDAQ Staff Determination; Alexza to Request Hearing with NASDAQ Listing Qualifications Panel"
12/21/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Alexza Pharmaceuticals Announces Interim Results from its Phase 2a Study of AZ-002 in Epilepsy Patients"
11/05/2015 8-K Quarterly results
Docs: "Alexza Reports 2015 Third Quarter Financial Results"
10/30/2015 8-K Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Alexza Pharmaceuticals Announces Intent to Reacquire U.S. Rights for ADASUVE ® inhalation powder"
10/30/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/14/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Ferrer and Alexza Pharmaceuticals Provide Update on ADASUVE ® European and Latin American Commercial Activities"
10/13/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/02/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Alexza Pharmaceuticals Announces Management Promotions"
09/28/2015 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "Promissory Note issued by the Registrant to Grupo Ferrer Internacional, S.A.",
"Stock Issuance Agreement between the Registrant and Grupo Ferrer Internacional, S.A.",
"Alexza Retains Guggenheim Securities, LLC to Explore Strategic Options"
08/06/2015 8-K Quarterly results
Docs: "Alexza Reports 2015 Second Quarter Financial Results"
07/24/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/25/2015 8-K Submission of Matters to a Vote of Security Holders
06/23/2015 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
06/18/2015 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Alexza Amends ADASUVE ® Commercial Partnership Agreements"
06/11/2015 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter from Ernst & Young LLP to the Securities and Exchange Commission"
05/22/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Release Agreement by and between the Company and Robert A. Lippe"
05/06/2015 8-K Quarterly results
Docs: "Alexza Reports 2015 First Quarter Financial Results"
04/29/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Alexza Pharmaceuticals Announces Management Promotions"
03/09/2015 8-K Quarterly results
Docs: "Alexza Reports Fourth Quarter and Year End 2014 Financial Results"
02/17/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "2015 Cash Bonus Plan"
01/23/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/22/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Alexza Pharmaceuticals Initiates Phase 2a Study of AZ-002 in Epilepsy Patients"
12/23/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy